ENTRY       hsa05410                    Pathway
NAME        Hypertrophic cardiomyopathy - Homo sapiens (human)
DESCRIPTION Hypertrophic cardiomyopathy (HCM) is a primary myocardial disorder with an autosomal dominant pattern of inheritance that is characterized by hypertrophy of the left ventricles with histological features of myocyte hypertrophy, myfibrillar disarray, and interstitial fibrosis. HCM is one of the most common inherited cardiac disorders, with a prevalence in young adults of 1 in 500. Hundreds of mutations in the genes that encode protein constituents of the sarcomere have been identified in HCM. These mutations increase the Ca2+ sensitivity of cardiac myofilaments. Increased myofilament Ca2+ sensitivity is expected to increase the ATP utilization by actomyosin at submaximal Ca2+ concentrations, which might cause an imbalance in energy supply and demand in the heart under severe stress. The inefficient use of ATP suggests that an inability to maintain normal ATP levels could be the central abnormality. This theory might be supported by the discovery of the role of a mutant PRKAG2 gene in HCM, which in active form acts as a central sensing mechanism protecting cells from depletion of ATP supplies. The increase in the myfilament Ca2+ sensitivity well account for the diastolic dysfunction of model animals as well as human patients of HCM. It has been widely proposed that left ventricular hypertrophy is not a primary manifestation but develops as compensatory response to sarcomere dysfunction.
CLASS       Human Diseases; Cardiovascular disease
PATHWAY_MAP hsa05410  Hypertrophic cardiomyopathy
DISEASE     H00292  Hypertrophic cardiomyopathy
DRUG        D12253  Aficamten (USAN/INN)
            D12265  Mavacamten (JAN/USAN/INN)
ORGANISM    Homo sapiens (human) [GN:hsa]
GENE        10368  CACNG3; calcium voltage-gated channel auxiliary subunit gamma 3 [KO:K04868]
            10369  CACNG2; calcium voltage-gated channel auxiliary subunit gamma 2 [KO:K04867]
            137868  SGCZ; sarcoglycan zeta [KO:K27062]
            1605  DAG1; dystroglycan 1 [KO:K06265]
            1636  ACE; angiotensin I converting enzyme [KO:K01283] [EC:3.4.15.1]
            1674  DES; desmin [KO:K07610]
            1756  DMD; dystrophin [KO:K10366]
            183  AGT; angiotensinogen [KO:K09821]
            1837  DTNA; dystrobrevin alpha [KO:K26998]
            1906  EDN1; endothelin 1 [KO:K16366]
            2010  EMD; emerin [KO:K12569]
            22801  ITGA11; integrin subunit alpha 11 [KO:K06587]
            27091  CACNG5; calcium voltage-gated channel auxiliary subunit gamma 5 [KO:K04870]
            27092  CACNG4; calcium voltage-gated channel auxiliary subunit gamma 4 [KO:K04869]
            284217  LAMA1; laminin subunit alpha 1 [KO:K05637]
            3479  IGF1; insulin like growth factor 1 [KO:K05459]
            3569  IL6; interleukin 6 [KO:K05405]
            3655  ITGA6; integrin subunit alpha 6 [KO:K06485]
            3672  ITGA1; integrin subunit alpha 1 [KO:K06480]
            3673  ITGA2; integrin subunit alpha 2 [KO:K06481]
            3674  ITGA2B; integrin subunit alpha 2b [KO:K06476]
            3675  ITGA3; integrin subunit alpha 3 [KO:K06482]
            3676  ITGA4; integrin subunit alpha 4 [KO:K06483]
            3678  ITGA5; integrin subunit alpha 5 [KO:K06484]
            3679  ITGA7; integrin subunit alpha 7 [KO:K06583]
            3680  ITGA9; integrin subunit alpha 9 [KO:K06585]
            3685  ITGAV; integrin subunit alpha V [KO:K06487]
            3688  ITGB1; integrin subunit beta 1 [KO:K05719]
            3690  ITGB3; integrin subunit beta 3 [KO:K06493]
            3691  ITGB4; integrin subunit beta 4 [KO:K06525]
            3693  ITGB5; integrin subunit beta 5 [KO:K06588]
            3694  ITGB6; integrin subunit beta 6 [KO:K06589]
            3695  ITGB7; integrin subunit beta 7 [KO:K06590]
            3696  ITGB8; integrin subunit beta 8 [KO:K06591]
            3908  LAMA2; laminin subunit alpha 2 [KO:K05637]
            4000  LMNA; lamin A/C [KO:K12641]
            4607  MYBPC3; myosin binding protein C3 [KO:K12568]
            4624  MYH6; myosin heavy chain 6 [KO:K17751]
            4625  MYH7; myosin heavy chain 7 [KO:K17751]
            4633  MYL2; myosin light chain 2 [KO:K10351]
            4634  MYL3; myosin light chain 3 [KO:K12749]
            4842  NOS1; nitric oxide synthase 1 [KO:K13240] [EC:1.14.13.39]
            487  ATP2A1; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1 [KO:K05853] [EC:7.2.2.10]
            488  ATP2A2; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 [KO:K05853] [EC:7.2.2.10]
            489  ATP2A3; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3 [KO:K05853] [EC:7.2.2.10]
            51422  PRKAG2; protein kinase AMP-activated non-catalytic subunit gamma 2 [KO:K07200]
            53632  PRKAG3; protein kinase AMP-activated non-catalytic subunit gamma 3 [KO:K07200]
            5562  PRKAA1; protein kinase AMP-activated catalytic subunit alpha 1 [KO:K07198] [EC:2.7.11.31]
            5563  PRKAA2; protein kinase AMP-activated catalytic subunit alpha 2 [KO:K07198] [EC:2.7.11.31]
            5564  PRKAB1; protein kinase AMP-activated non-catalytic subunit beta 1 [KO:K07199]
            5565  PRKAB2; protein kinase AMP-activated non-catalytic subunit beta 2 [KO:K07199]
            5571  PRKAG1; protein kinase AMP-activated non-catalytic subunit gamma 1 [KO:K07200]
            55799  CACNA2D3; calcium voltage-gated channel auxiliary subunit alpha2delta 3 [KO:K04860]
            59283  CACNG8; calcium voltage-gated channel auxiliary subunit gamma 8 [KO:K04873]
            59284  CACNG7; calcium voltage-gated channel auxiliary subunit gamma 7 [KO:K04872]
            59285  CACNG6; calcium voltage-gated channel auxiliary subunit gamma 6 [KO:K04871]
            60  ACTB; actin beta [KO:K05692]
            6262  RYR2; ryanodine receptor 2 [KO:K04962]
            6442  SGCA; sarcoglycan alpha [KO:K12565]
            6443  SGCB; sarcoglycan beta [KO:K12566]
            6444  SGCD; sarcoglycan delta [KO:K12563]
            6445  SGCG; sarcoglycan gamma [KO:K12564]
            6543  SLC8A2; solute carrier family 8 member A2 [KO:K05849]
            6546  SLC8A1; solute carrier family 8 member A1 [KO:K05849]
            6547  SLC8A3; solute carrier family 8 member A3 [KO:K05849]
            6640  SNTA1; syntrophin alpha 1 [KO:K24063]
            6641  SNTB1; syntrophin beta 1 [KO:K24064]
            6645  SNTB2; syntrophin beta 2 [KO:K24064]
            70  ACTC1; actin alpha cardiac muscle 1 [KO:K12314]
            7040  TGFB1; transforming growth factor beta 1 [KO:K13375]
            7042  TGFB2; transforming growth factor beta 2 [KO:K13376]
            7043  TGFB3; transforming growth factor beta 3 [KO:K13377]
            71  ACTG1; actin gamma 1 [KO:K05692]
            7124  TNF; tumor necrosis factor [KO:K03156]
            7134  TNNC1; troponin C1, slow skeletal and cardiac type [KO:K05865]
            7137  TNNI3; troponin I3, cardiac type [KO:K12044]
            7139  TNNT2; troponin T2, cardiac type [KO:K12045]
            7168  TPM1; tropomyosin 1 [KO:K10373]
            7169  TPM2; tropomyosin 2 [KO:K10374]
            7170  TPM3; tropomyosin 3 [KO:K09290]
            7171  TPM4; tropomyosin 4 [KO:K10375]
            7273  TTN; titin [KO:K12567] [EC:2.7.11.1]
            775  CACNA1C; calcium voltage-gated channel subunit alpha1 C [KO:K04850]
            776  CACNA1D; calcium voltage-gated channel subunit alpha1 D [KO:K04851]
            778  CACNA1F; calcium voltage-gated channel subunit alpha1 F [KO:K04853]
            779  CACNA1S; calcium voltage-gated channel subunit alpha1 S [KO:K04857]
            781  CACNA2D1; calcium voltage-gated channel auxiliary subunit alpha2delta 1 [KO:K04858]
            782  CACNB1; calcium voltage-gated channel auxiliary subunit beta 1 [KO:K04862]
            783  CACNB2; calcium voltage-gated channel auxiliary subunit beta 2 [KO:K04863]
            784  CACNB3; calcium voltage-gated channel auxiliary subunit beta 3 [KO:K04864]
            785  CACNB4; calcium voltage-gated channel auxiliary subunit beta 4 [KO:K04865]
            786  CACNG1; calcium voltage-gated channel auxiliary subunit gamma 1 [KO:K04866]
            8082  SSPN; sarcospan [KO:K22194]
            8515  ITGA10; integrin subunit alpha 10 [KO:K06586]
            8516  ITGA8; integrin subunit alpha 8 [KO:K06584]
            859  CAV3; caveolin 3 [KO:K12959]
            8910  SGCE; sarcoglycan epsilon [KO:K27061]
            9254  CACNA2D2; calcium voltage-gated channel auxiliary subunit alpha2delta 2 [KO:K04859]
            93589  CACNA2D4; calcium voltage-gated channel auxiliary subunit alpha2delta 4 [KO:K04861]
COMPOUND    C00002  ATP
            C00076  Calcium cation
            C01330  Sodium cation
REFERENCE   PMID:12270949
  AUTHORS   Fatkin D, Graham RM
  TITLE     Molecular mechanisms of inherited cardiomyopathies.
  JOURNAL   Physiol Rev 82:945-80 (2002)
            DOI:10.1152/physrev.00012.2002
REFERENCE   PMID:12844200
  AUTHORS   Moolman-Smook JC, Mayosi BM, Brink PA, Corfield VA
  TITLE     Molecular genetics of cardiomyopathy: changing times, shifting paradigms.
  JOURNAL   Cardiovasc J S Afr 14:145-55 (2003)
REFERENCE   PMID:14711353
  AUTHORS   Taylor MR, Carniel E, Mestroni L
  TITLE     Familial hypertrophic cardiomyopathy: clinical features, molecular genetics and molecular genetic testing.
  JOURNAL   Expert Rev Mol Diagn 4:99-113 (2004)
            DOI:10.1586/14737159.4.1.99
REFERENCE   PMID:10615904
  AUTHORS   Marian AJ
  TITLE     Pathogenesis of diverse clinical and pathological phenotypes in hypertrophic cardiomyopathy.
  JOURNAL   Lancet 355:58-60 (2000)
            DOI:10.1016/S0140-6736(99)06187-5
REFERENCE   PMID:11371514
  AUTHORS   Blair E, Redwood C, Ashrafian H, Oliveira M, Broxholme J, Kerr B, Salmon A, Ostman-Smith I, Watkins H
  TITLE     Mutations in the gamma(2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis.
  JOURNAL   Hum Mol Genet 10:1215-20 (2001)
            DOI:10.1093/hmg/10.11.1215
REFERENCE   PMID:11716909
  AUTHORS   Franz WM, Muller OJ, Katus HA
  TITLE     Cardiomyopathies: from genetics to the prospect of treatment.
  JOURNAL   Lancet 358:1627-37 (2001)
            DOI:10.1016/S0140-6736(01)06657-0
REFERENCE   PMID:18056765
  AUTHORS   Morimoto S
  TITLE     Sarcomeric proteins and inherited cardiomyopathies.
  JOURNAL   Cardiovasc Res 77:659-66 (2008)
            DOI:10.1093/cvr/cvm084
REFERENCE   PMID:19136482
  AUTHORS   Cambronero F, Marin F, Roldan V, Hernandez-Romero D, Valdes M, Lip GY
  TITLE     Biomarkers of pathophysiology in hypertrophic cardiomyopathy: implications for clinical management and prognosis.
  JOURNAL   Eur Heart J 30:139-51 (2009)
            DOI:10.1093/eurheartj/ehn538
REFERENCE   PMID:11805847
  AUTHORS   Towbin JA, Bowles NE
  TITLE     The failing heart.
  JOURNAL   Nature 415:227-33 (2002)
            DOI:10.1038/415227a
REFERENCE   PMID:11225594
  AUTHORS   Sorajja P, Elliott PM, McKenna WJ
  TITLE     The molecular genetics of hypertrophic cardiomyopathy: prognostic implications.
  JOURNAL   Europace 2:4-14 (2000)
            DOI:10.1053/eupc.1999.0067
REFERENCE   PMID:18572189
  AUTHORS   Landstrom AP, Parvatiyar MS, Pinto JR, Marquardt ML, Bos JM, Tester DJ, Ommen SR, Potter JD, Ackerman MJ
  TITLE     Molecular and functional characterization of novel hypertrophic cardiomyopathy susceptibility mutations in TNNC1-encoded troponin C.
  JOURNAL   J Mol Cell Cardiol 45:281-8 (2008)
            DOI:10.1016/j.yjmcc.2008.05.003
REL_PATHWAY hsa04260  Cardiac muscle contraction
            hsa04350  TGF-beta signaling pathway
            hsa04512  ECM-receptor interaction
            hsa04614  Renin-angiotensin system
            hsa04630  JAK-STAT signaling pathway
KO_PATHWAY  ko05410
///
